Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancer Biology & Therapy|March 23, 2018
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapyAlbert Grinshpun, Nancy Gavert, Roy Zvi Granit, et al.Nature Cancer|February 5, 2022
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapyAdi Jacob Berger, Elinor Gigi, Lana Kupershmidt, et al.Cell|September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsLian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.Nature Cancer|February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancerNancy Gavert, Yaara Zwang, Roi Weiser, et al.Frontiers in Medicine|October 16, 2023
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapyShay Golan, Vered Bar, Seth J Salpeter, et al.Nature Cancer|November 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signaturesElinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, et al.Science (New York, N.Y.)|September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T Geller, Michal Barzily-Rokni, Tal Danino, et al.Science (New York, N.Y.)|May 30, 2020
The human tumor microbiome is composed of tumor type-specific intracellular bacteriaDeborah Nejman, Ilana Livyatan, Garold Fuks, et al.Pageof 6